Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN) Cristina Tejera-PérezAna Chicothe Área de Diabetes-SEEN Guidelines Open access 15 May 2023 Pages: 1077 - 1091
Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes Naresh KanumilliJaved ButlerAlice Cheng Review Open access 18 May 2023 Pages: 1093 - 1110
Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus Ellie KelepourisWendy St. PeterEugene E. Wright Review Open access 20 May 2023 Pages: 1111 - 1136
Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People in India: A Multicenter Feasibility Randomized Controlled Trial Kaushik ChattopadhyayPallavi MishraYOGA-DP Study Team Original Research Open access 31 March 2023 Pages: 1137 - 1154
Correction to: Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People in India: A Multicenter Feasibility Randomized Controlled Trial Kaushik ChattopadhyayPallavi MishraYOGA-DP Study Team Publisher Correction Open access 24 May 2023 Pages: 1155 - 1156
Real-World Patterns of Basal Insulin Use with Other Diabetes Medications Among People with Type 2 Diabetes Between 2014 and 2020 David SchapiroRattan JunejaMagaly Perez-Nieves Original Research Open access 15 May 2023 Pages: 1157 - 1174
Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan Ruriko KotoAkihiro NakajimaKen Sugimoto Original Research Open access 17 May 2023 Pages: 1175 - 1192
Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis Shelby SydnorSwarnendu ChatterjeeFederico Felizzi Original Research Open access 17 May 2023 Pages: 1193 - 1216
Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study Danijel ĐekićMirjana BojićSvetla Mihalevska Original Research Open access 21 May 2023 Pages: 1217 - 1229
Low Initial Adherence with Flash Glucose Monitoring is Not a Predictor of Long-Term Glycemic Outcomes: Longitudinal Analysis of the Association Between Experience, Adherence, and Glucose Control for FreeStyle Libre Users Jan ŠoupalKalvin KaoMartin Prázný Original Research Open access 22 May 2023 Pages: 1231 - 1240